R. Batash et al., Glioblastoma Multiforme, Diagnosis and Treatment Recent Literature Review. Curr. Med. Chem. 24(27), 3002–3009 (2017)

Article  PubMed  CAS  Google Scholar 

D.A. Reardon et al., Immunomodulation for glioblastoma. Curr. Opin. Neurol. 30(3), 361–369 (2017)

Article  PubMed  CAS  Google Scholar 

Melhem, J.M., et al., Updates in IDH-Wildtype Glioblastoma. Neurotherapeutics. 31,1–19 (2022). https://doi.org/10.1007/s13311-022-01251-6

O.G. Taylor, J.S. Brzozowski, K.A. Skelding, Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets. Front. Oncol. 9, 963 (2019)

Article  PubMed  PubMed Central  Google Scholar 

C. Alifieris, D.T. Trafalis, Glioblastoma multiforme: Pathogenesis and treatment. Pharmacol. Ther. 152, 63–82 (2015)

Article  PubMed  CAS  Google Scholar 

A. Malmstrom et al., Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol. 13(9), 916–926 (2012)

Article  PubMed  Google Scholar 

L. Cheng et al., L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1. EMBO J. 30(5), 800–813 (2011)

Article  PubMed  PubMed Central  CAS  Google Scholar 

M.E. Hardee et al., Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-beta. Cancer Res. 72(16), 4119–4129 (2012)

Article  PubMed  PubMed Central  CAS  Google Scholar 

S.P. Caragher, S. Sachdev, A. Ahmed, Radiotherapy and Glioma Stem Cells: Searching for Chinks in Cellular Armor. Curr. Stem Cell Rep. 3(4), 348–357 (2017)

Article  PubMed  PubMed Central  CAS  Google Scholar 

J.A. Fritzell et al., Role of DNA mismatch repair in the cytotoxicity of ionizing radiation. Cancer Res. 57(22), 5143–5147 (1997)

PubMed  CAS  Google Scholar 

S. Bao et al., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120), 756–760 (2006)

Article  PubMed  CAS  Google Scholar 

F. De Bacco et al., MET inhibition overcomes radiation resistance of glioblastoma stem-like cells. EMBO Mol. Med. 8(5), 550–568 (2016)

Article  PubMed  PubMed Central  Google Scholar 

K. Tamura et al., Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy. J. Neurosurg. 119(5), 1145–1155 (2013)

Article  PubMed  Google Scholar 

S.K. Singh et al., Identification of human brain tumour initiating cells. Nature 432(7015), 396–401 (2004)

Article  PubMed  CAS  Google Scholar 

A. Wyllie, Apoptosis. Clues in the p53 murder mystery. Nature 389(6648), 237–8 (1997)

Article  PubMed  CAS  Google Scholar 

F. Myokai et al., A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment. Proc. Natl. Acad. Sci. U. S. A. 96(8), 4518–4523 (1999)

Article  PubMed  PubMed Central  CAS  Google Scholar 

X. Tang, M.J. Fenton, S. Amar, Identification and functional characterization of a novel binding site on TNF-alpha promoter. Proc. Natl. Acad. Sci. USA 100(7), 4096–4101 (2003)

Article  PubMed  PubMed Central  CAS  Google Scholar 

X. Tang et al., LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines. Proc. Natl. Acad. Sci. USA 102(14), 5132–5137 (2005)

Article  PubMed  PubMed Central  CAS  Google Scholar 

K.P.L. Bhat et al., Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. Cancer Cell 24(3), 331–346 (2013)

Article  PubMed  CAS  Google Scholar 

D.W. Lee et al., The NF-kappaB RelB protein is an oncogenic driver of mesenchymal glioma. PLoS ONE 8(2), e57489 (2013)

Article  PubMed  PubMed Central  CAS  Google Scholar 

J. Ji et al., TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα. Cell Death Differ. 28(1), 367–381 (2021)

Article  PubMed  CAS  Google Scholar 

J. Lee, E. Hoxha, H.R. Song, A novel NFIA-NFκB feed-forward loop contributes to glioblastoma cell survival. Neuro. Oncol. 19(4), 524–534 (2017)

PubMed  CAS  Google Scholar 

D.N. Louis et al., The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta. Neuropathol. 131(6), 803–820 (2016)

Article  PubMed  Google Scholar 

K.P.L. Bhat et al., Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell 24(3), 331–346 (2013)

Article  PubMed  CAS  Google Scholar 

M.S. Carro et al., The transcriptional network for mesenchymal transformation of brain tumours. Nature 463(7279), 318–325 (2010)

Article  PubMed  CAS  Google Scholar 

X. Tang, S. Amar, Kavain Involvement in LPS-Induced Signaling Pathways. J. Cell Biochem. 117(10), 2272–2280 (2016)

Article  PubMed  CAS  Google Scholar 

X. Tang, S. Amar, Kavain Inhibition of LPS-Induced TNF-alpha via ERK/LITAF. Toxicol. Res. (Camb.) 5(1), 188–196 (2016)

Article  PubMed  Google Scholar 

P. Wang et al., Enzymes and Pathways of Kavain Bioactivation and Biotransformation. Chem. Res. Toxicol. 32(7), 1335–1342 (2019)

Article  PubMed  CAS  Google Scholar 

J. Zou et al., Lipopolysaccharide-induced tumor necrosis factor-alpha factor enhances inflammation and is associated with cancer (Review). Mol. Med. Rep. 12(5), 6399–6404 (2015)

Article  PubMed  CAS  Google Scholar 

A.J. Shirk et al., SIMPLE interacts with NEDD4 and TSG101: evidence for a role in lysosomal sorting and implications for Charcot-Marie-Tooth disease. J. Neurosci. Res. 82(1), 43–50 (2005)

Article  PubMed  CAS  Google Scholar 

S.M. Lee, L.S. Chin, L. Li, Charcot-Marie-Tooth disease-linked protein SIMPLE functions with the ESCRT machinery in endosomal trafficking. J. Cell. Biol. 199(5), 799–816 (2012)

Article  PubMed  PubMed Central  CAS  Google Scholar 

M.H. Pittler, E. Ernst, Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J. Clin. Psychopharmacol. 20(1), 84–89 (2000)

Article  PubMed  CAS  Google Scholar 

C.M. White, The Pharmacology, Pharmacokinetics, Efficacy, and Adverse Events Associated With Kava. J. Clin. Pharmacol. 58(11), 1396–1405 (2018)

Article  PubMed  CAS  Google Scholar 

M.P. Pollastri et al., Identification and characterization of kava-derived compounds mediating TNF-alpha suppression. Chem. Biol. Drug Des. 74(2), 121–128 (2009)

Article  PubMed  PubMed Central  CAS  Google Scholar